The global healthcare contract research organization (CRO) market is anticipated to expand at a stable CAGR above 6.5% during the forecast period 2018 to 2026. According to the report titled “Healthcare contract research organization (CRO) Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018-2026”. Increasing preferences for outsourcing activities due to cost and time efficiency and increasing R&D investments have increased the growth of the global healthcare contract research organization (CRO) market. The healthcare contract research organization (CRO) market in the North America is likely to expand at significant CAGR due to numerous advancements in healthcare infrastructure and presence of large number of pharmaceutical and biotechnology organizations in the region.
Download Sample Copy of this Report@ https://www.acumenresearchandconsulting.com/request-sample/934
Growing clinical trials to boost the growth of the clinical segment
In terms of type, the global healthcare contract research organization (CRO) market is bifurcated into drug discovery, pre-clinical and clinical. Clinical segment accumulated the highest market share in 2017 and anticipated to dominate the market throughout the forecast period. The growth of the market can be attributed to various factors such as increase in clinical trial activities, increased R&D investments of pharmaceutical and biopharmaceutical companies, and rising biologics and biosimilars markets. This is increasing the growth of the clinical segment. Technological advancements in medical devices, adoption of point-of-care (POC) testing and increasing incidence of chronic diseases are the major factors supporting the growth of clinical segment. The clinical segment can further be divided into phase I, phase II, phase III, and phase IV trial services. Phase III segment is expected to show significant growth during the forecast period. Furthermore, pre-clinical segment is also forecasted to grow at considerable pace throughout the forecast period as it involve testing on animals in order to accomplish approval of clinical trial on human subjects.
On the other hand, on the basis of service, the clinical monitoring service segment accumulated the highest revenue share in 2017 owing to the growing health concerns among people and increasing spending on clinical technologies. For relatively recent years, CROs are outsourcing clinical research because of different reasons, for example, cost adequacy, skill, and reduced burden on management. Changing business sector patterns are convincing pharmaceutical organizations to diminish their settled expenses in order to offer effective solutions.
Browse Full Report with Table of Content, List of Table and Figures@ https://www.acumenresearchandconsulting.com/healthcare-contract-research-organization-cro-market
Development of healthcare infrastructure and improving economic conditions in Asia Pacific to create more opportunities in the market
Geographically, the global healthcare contract research organization (CRO) market has been divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. In 2017, Asia Pacific was the dominant revenue contributing region owing to, improving economic conditions, large and diverse patient pool and development in healthcare infrastructure in various countries such as India, China and Japan. Expanding enthusiasm of the western association to explore new chances and to extend their geological presence are probably going to drive the development of the regional market. Moreover, growing frequency of lifestyle diseases, such as hypertension, mellitus, and diabetes because of increment in stationary way of life and changing dietary propensities is additionally anticipated to feed the development of the market in Asia Pacific. North America is also projected to grow at significant rate over the forecast period due to majority of outsourcing activities, growing per capita expenditure on healthcare industry and increasing focus on minimizing R&D cost. Additionally, North America is leading region to perform large number of clinical trials worldwide. Europe is also projected to grow significantly over the forecast period.
Quintiles, HARTMANN, Pharmaceutical Product Development, Covance, are likely to continue their domination in global healthcare contract research organization (CRO) market.
The company profiling of key players in the global healthcare contract research organization (CRO) market includes company overview, major business strategies and revenues. The key players of the market are Quintiles, LLC (PPD), PAREXEL International Corporation, Medidata Solutions, Pharmaceutical Product Development Charles River Laboratories (CRL), Covance, PRA Health Sciences ICON Plc, and inVentiv Health Inc. Leading industry participant are primarily focusing on strategic collaborations and R&D in order to provide cost and time efficient solutions to clients.
TABLE OF CONTENT
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Healthcare Contract Research Organization (CRO)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Healthcare Contract Research Organization (CRO) Market By Product
1.2.2.1. Global Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Healthcare Contract Research Organization (CRO) Market Revenue Share By Product in 2017
1.2.2.3. Drug Discovery
1.2.2.4. Pre-Clinical
1.2.2.5. Clinical
1.2.2.6. Others
1.2.3. Healthcare Contract Research Organization (CRO) Market By Service
1.2.3.1. Global Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate Comparison By Service (2015-2026)
1.2.3.2. Global Healthcare Contract Research Organization (CRO) Market Revenue Share By Service in 2017
1.2.3.3. Project Management/Clinical Supply Management
1.2.3.4. Data Management
1.2.3.5. Regulatory/Medical Affairs
1.2.3.6. Medical Writing
1.2.3.7. Clinical Monitoring
1.2.3.8. Quality Management/ Assurance
1.2.3.9. Bio-statistics
1.2.3.10. Investigator Payments
1.2.3.11. Laboratory
1.2.3.12. Patient and site Recruitment
1.2.3.13. Technology
1.2.3.14. Others
1.2.4. Healthcare Contract Research Organization (CRO) Market by Geography
1.2.4.1. Global Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.1.1. Definition of Healthcare Contract Research Organization (CRO)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Healthcare Contract Research Organization (CRO) Market By Product
1.2.2.1. Global Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Healthcare Contract Research Organization (CRO) Market Revenue Share By Product in 2017
1.2.2.3. Drug Discovery
1.2.2.4. Pre-Clinical
1.2.2.5. Clinical
1.2.2.6. Others
1.2.3. Healthcare Contract Research Organization (CRO) Market By Service
1.2.3.1. Global Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate Comparison By Service (2015-2026)
1.2.3.2. Global Healthcare Contract Research Organization (CRO) Market Revenue Share By Service in 2017
1.2.3.3. Project Management/Clinical Supply Management
1.2.3.4. Data Management
1.2.3.5. Regulatory/Medical Affairs
1.2.3.6. Medical Writing
1.2.3.7. Clinical Monitoring
1.2.3.8. Quality Management/ Assurance
1.2.3.9. Bio-statistics
1.2.3.10. Investigator Payments
1.2.3.11. Laboratory
1.2.3.12. Patient and site Recruitment
1.2.3.13. Technology
1.2.3.14. Others
1.2.4. Healthcare Contract Research Organization (CRO) Market by Geography
1.2.4.1. Global Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate (2015-2026)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Healthcare Contract Research Organization (CRO) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Healthcare Contract Research Organization (CRO) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Healthcare Contract Research Organization (CRO) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Healthcare Contract Research Organization (CRO) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Healthcare Contract Research Organization (CRO) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Healthcare Contract Research Organization (CRO) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Healthcare Contract Research Organization (CRO) Major Manufacturers in 2017
CHAPTER 4. HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY PRODUCT
4.1. Global Healthcare Contract Research Organization (CRO) Revenue By Product
4.2. Drug Discovery
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Pre-Clinical
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Clinical
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.2. Drug Discovery
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Pre-Clinical
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Clinical
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 5. HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY SERVICE
5.1. Global Healthcare Contract Research Organization (CRO) Revenue By Service
5.2. Project Management/Clinical Supply Management
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Data Management
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Regulatory/Medical Affairs
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Medical Writing
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Clinical Monitoring
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.7. Quality Management/ Assurance
5.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.8. Bio-statistics
5.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.9. Investigator Payments
5.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.10. Laboratory
5.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.11. Patient and site Recruitment
5.11.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.11.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.12. Technology
5.12.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.12.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.13. Others
5.13.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.13.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.2. Project Management/Clinical Supply Management
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Data Management
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. Regulatory/Medical Affairs
5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Medical Writing
5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.6. Clinical Monitoring
5.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.7. Quality Management/ Assurance
5.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.8. Bio-statistics
5.8.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.8.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.9. Investigator Payments
5.9.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.9.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.10. Laboratory
5.10.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.10.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.11. Patient and site Recruitment
5.11.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.11.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.12. Technology
5.12.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.12.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.13. Others
5.13.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.13.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
CHAPTER 6. NORTH AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
6.1. North America Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2. North America Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Healthcare Contract Research Organization (CRO) Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.2. North America Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Healthcare Contract Research Organization (CRO) Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
6.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
CHAPTER 7. EUROPE HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
7.1. Europe Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. Europe Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.2. Europe Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.6.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
7.7.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
CHAPTER 8. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
8.1. Asia-Pacific Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Asia-Pacific Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.2. Asia-Pacific Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
8.8.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
CHAPTER 9. LATIN AMERICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
9.1. Latin America Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Latin America Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.2. Latin America Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
CHAPTER 10. MIDDLE EAST HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
10.1. Middle East Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Middle East Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.2. Middle East Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
CHAPTER 11. AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET BY COUNTRY
11.1. Africa Healthcare Contract Research Organization (CRO) Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Africa Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.2. Africa Healthcare Contract Research Organization (CRO) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Service, 2015 – 2026 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Laboratory Corporation of America Holdings
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. PRA Health Sciences
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Charles River Laboratories, Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Pharmaceutical Product Development
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. LLC
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Quintiles IMS Holdings, Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. PAREXEL International Corporation
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. inVentiv Health, Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. ICON plc
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Others
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. PRA Health Sciences
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Charles River Laboratories, Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Pharmaceutical Product Development
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. LLC
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Quintiles IMS Holdings, Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. PAREXEL International Corporation
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. inVentiv Health, Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. ICON plc
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Others
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
Inquiry Before Buying@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/934
The report is readily available and can be dispatched immediately after payment confirmation.
To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/934
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
0 Comments
Get More Detail Study, Visit Here: https://www.acumenresearchandconsulting.com/